La Jolla, California 92093


Purpose:

This study evaluates the effectiveness of Behavioral Activation (BA) therapy vs Support and Information for reducing risk for emotional and cardiovascular diseases in Alzheimer's caregivers. Half of participants will receive BA and the other half will receive support and information.


Study summary:

The burden of caring for a loved-one with Alzheimer's disease is associated with adverse psychological and general health consequences for the caregiver. These consequences including risk for depression, cardiovascular disease, and earlier mortality. Because preliminary work has demonstrated that an educational programs for caregivers reduce the negative affect associated with caregiving, the investigators wish to determine whether improving mood can also modify pathophysiological changes that have been linked to risk for developing cardiovascular disease. The investigators aims are to determine whether a 6-week Behavioral Activation (BA) intervention, followed by 3 booster sessions over a period of 6 months, compared to an Information-Support (IS) intervention will be associated with significant improvement in indicators of vascular pathology, modification of psychobiological markers that have been associated with cardiovascular parameters, and to determine whether improvements in indicators of vascular parameters will be mediated by treatment related change in measures of distress and markers of cardiovascular disease risk.


Criteria:

Inclusion Criteria: - Aged 55 years or older. - Providing in-home care to a spouse with dementia. Exclusion Criteria: - Taking Coumarin anticoagulants. - Taking nitrates or niacin. - Taking non-selective β-blockers. - Glucocorticoid use in the 2 weeks prior to enrollment. - Taking Aldomet or labetalol. - Neither the caregiver nor Alzheimer's patient can be diagnosed with a terminal illness with a life expectancy of less than 1 year - Cognitive impairment - Caregivers enrolled in another intervention study or receiving psychotherapy to improve well-being or reduce distress - Blood pressure >200/120 mm Hg


NCT ID:

NCT02317523


Primary Contact:

Principal Investigator
Brent T Mausbach, PhD
University of California, San Diego

Brent T Mausbach, PhD
Phone: 858-822-7529


Backup Contact:

Jean-Loup Bitterlin
Phone: 858-534-9479


Location Contact:

La Jolla, California 92093
United States

Brent Mausbach, PhD

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.